Close
Help
Need Help?





JOURNAL

Clinical Medicine Insights: Blood Disorders

58,060 Journal Article Views | Journal Analytics

C1 Esterase Inhibitor (Human) for the Treatment of Acute Hereditary Angioedema

Submit a Paper



Publication Date: 25 Sep 2011

Type: Review

Journal: Clinical Medicine Insights: Blood Disorders

Citation: Clinical Medicine Insights: Blood Disorders 2011:4 21-30

doi: 10.4137/CMBD.S4090

Abstract

Hereditary angioedema (HAE) is a relatively rare disease characterized by acute episodes of swelling. These swellings can be disfiguring, painful and life-threatening. Since the symptoms occur in different areas and most patients experience a delay in their diagnosis, resulting in unnecessary suffering and dangerous situations. HAE can have a tremendous impact on the quality of life.

The major genetic deficiency in this disorder is either an absent or nonfunctional C1INH which regulates the complement, fibrinolitic, kalikrein and plasmin pathways.


Downloads

PDF  (584.40 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)




Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
I have reviewed nearly a dozen manuscripts for Libertas Academica, and the whole process is smooth and fast. I think Libertas Academica is a high quality platform for scientists around the world to publish their researches in an easy and timely manner. With the increased impact factors, I encourage more authors submit their papers to journals in Libertas Academica.
Dr Jike Cui (Harvard Medical School, Boston, MA, USA)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results